8-K: Beneficient Closes $1.36 Million Primary Capital Transaction, Issues Series B-5 Preferred Stock

Beneficient closed a $1.36 million primary capital transaction, issuing Series B-5 Resettable Convertible Preferred Stock in exchange for a limited partner interest in an investment fund.

Summary

• Beneficient, through a subsidiary, completed a primary capital transaction on December 31, 2024, acquiring a limited partner interest in an investment fund with a net asset value of $1,361,926.
• In exchange, the customer received 136,193 shares of Series B-5 Resettable Convertible Preferred Stock.
• This preferred stock is convertible into Class A Common Stock at an initial conversion price of $0.6940 per share, subject to customary adjustments.
• A total of 1,962,435 shares of Class A Common Stock may be issued upon conversion of the Series B-5 Preferred Stock.
• The Series B-5 Preferred Stock has a mandatory conversion feature tied to the company's SEC filings and resale registration, with a potential reset of the conversion price on the last day of each month.
• The company filed a certificate of designation for the Series B-5 Preferred Stock on December 30, 2024, outlining its rights, preferences, and restrictions.
• The transaction is expected to increase the collateral for the company's ExAlt loan portfolio by approximately $1.36 million.
• The company estimates this transaction will add approximately $450,000 to its tangible book value attributable to public stockholders, and an aggregate of approximately $10.23 million when combined with other recent transactions.

Sentiment

Score: 7

Explanation: The document is generally positive, highlighting a successful capital transaction and its expected benefits. However, the complexity of the preferred stock terms and the inherent risks in forward-looking statements temper the overall sentiment.

Positives

• The transaction provides primary capital to the company and increases the collateral for its ExAlt loan portfolio.
• The issuance of Series B-5 Preferred Stock allows for potential future conversion into Class A Common Stock.
• The transaction is expected to increase the company's tangible book value attributable to public stockholders.
• The company is actively pursuing its core liquidity and primary capital business plan.

Negatives

• The Series B-5 Preferred Stock has a complex conversion structure with potential resets of the conversion price.
• The conversion of the Series B-5 Preferred Stock is subject to limitations based on beneficial ownership and Nasdaq rules.
• The Series B-5 Preferred Stock ranks junior to other series of preferred stock and all existing and future indebtedness of the company.

Risks

• The conversion of the Series B-5 Preferred Stock is subject to limitations based on beneficial ownership and Nasdaq rules, which could delay or prevent full conversion.
• The conversion price of the Series B-5 Preferred Stock is subject to resets, which could impact the number of Class A Common Stock shares issued upon conversion.
• The company's ability to meet the conditions for mandatory conversion of the Series B-5 Preferred Stock is dependent on its SEC filings and resale registration.
• The company's forward-looking statements are subject to risks and uncertainties that could affect actual results.

Future Outlook

The company plans to continue evaluating additional opportunities that align with its strategic objectives and build on the momentum of this transaction in 2025.

Management Comments

• Closing this transaction underscores our commitment to executing on our core liquidity and primary capital business plan by delivering innovative capital solutions for holders and managers of alternative assets, said, Beneficient management.
• We believe this financing reflects our ability to drive shareholder value while supporting impactful, vertically integrated investment strategies that enhance the value of the collateral backing our ExAlt loan portfolio.

Industry Context

This transaction reflects a trend in the alternative asset market where companies are seeking innovative capital solutions and liquidity options. Beneficient is positioning itself as a provider of these solutions through its technology-enabled platform.

Comparison to Industry Standards

• The issuance of convertible preferred stock is a common method for companies to raise capital, particularly in the alternative asset space.
• The conversion terms, including the reset feature and ownership limitations, are complex but not uncommon in such transactions.
• The focus on increasing tangible book value is a key metric for investors in the current market environment.
• The company's strategy of providing liquidity and primary capital solutions aligns with the needs of the alternative asset market, which often lacks efficient exit options.

Stakeholder Impact

• Shareholders may benefit from the increased tangible book value and potential future conversion of the preferred stock.
• The transaction provides liquidity and capital solutions for holders and managers of alternative assets.
• The company's employees may benefit from the company's growth and strategic initiatives.

Next Steps

• The company will seek stockholder approval for the issuance of Class A Common Stock upon conversion of the Series B-5 Preferred Stock.
• The company will continue to evaluate additional opportunities that align with its strategic objectives.

Key Dates

Keywords

primary capital, preferred stock, convertible stock, alternative assets, investment fund, Beneficient, ExAlt loan portfolio, tangible book value